As the use of adolescent use of GLP-1 medications surges, research looks into their safety and natural alternatives.

How many companion products, such as food supplements, will the GLP-1 drugs eventually succeed in bringing to the party?

It’s far from proven that the new weight loss drugs can and will be the answer for everybody with every type of counterproductive eating pattern.

Science does not always progress in an immaculate, untarnished linear fashion. There have been errors and oversights, and that is unlikely to change.

A new tailored approach to using GLP-1 receptor agonists for obesity management achieves nearly twice the weight loss.

No one wants to see minors sticking hypodermic needles into themselves. Some new devices being researched won’t require injections.

We continue discussing the alternatives to GLP-1 medications, including natural herbs and supplements. But those come with their own sets of side effects.

How often do doctors prescribe new weight loss drugs to kids? And what reservations and considerations drive their decisions?

What problems with Ozempic (and other semaglutide brands) have natural alternatives been found to avoid?

One recent study found that gene therapy converts Omega-6 to Omega-3 fatty acids in the body, in other words, turning “harmful fats” into “helpful fats.”

Two recent studies found that adding a digital component to health behavior counseling can reduce childhood obesity risk.

Who gets refeeding syndrome? Anyone who receives increased nutrition after a prolonged experience of starvation, and this includes a lot of people.

Journalist Kati Blocker published another follow-up story about Katie Peterson, who had already lost 330 pounds at that point, a considerable improvement.

With Halloween only one day away, let’s take a quick look at the advice pediatric obesity experts are giving to minimize candy consumption.

Is it universally accepted that an addict just doesn’t care? Is this why so many die from fentanyl?

Let’s take a look at how the thinking on obesity has shifted over time and what this means for public health and healthcare.

If you spot a teal pumpkin this year, the color does not simply mean “no candy,” although that concept in itself is quite valid — but there is a lot more to it.

Let’s figure out how to reduce the amount of junk the kids collect, how much they hold onto, and how much of it they ultimately consume.

Europe and the U.S. consider whether to provide coverage for GLP-1 agonists.

Check out our suggestions for Halloween fun that turn the spotlight away from the sugar treats and shift the emphasis to creativity and participation.

Halloween tends to set the tone for the rest of the holidays that cluster around the end of any year and the beginning of the next.

Pediatric obesity experts agree that behavioral interventions, used in conjunction with GLP-1 medications, can be more effective than a standalone tool.

Utilizing social media, women have taken it upon themselves to communicate with each other, sharing good news and bad news.

Some studies indicate that GLP-1 drugs in conjunction with pregnancy do pose a risk, but the FDA still warns women not to take them during pregnancy.

Obesity treatment has shifted away from advice about diet and exercise to a more scientific understanding of the disease.

Digital interventions are reshaping pediatric care across a range of conditions, including mental health and obesity management.

What is the one thing more disappointing than the fact that sugar is not good for us? Learning that sugar substitutes can also be very harmful.

September is the National Childhood Obesity News. To honor it, let’s look at some recent studies in various areas, from dengue fever to baby food nutrition.

One way or another, childhood obesity ends up being everybody’s problem. Agreement is universal on the importance of starting to fight it early.

A new study published in the New England Journal of Medicine sheds light on how GLP-1 drugs could play a critical role in treating obesity in younger children.